
Journal of Organometallic Chemistry p. 63 - 73 (1998)
Update date:2022-08-16
Topics:
Blair, Sharon L.
Hill, Ross H.
The photochemical reactions of Fe(CO)4PPh3 and Fe(CO)3(PPh3)2 as amorphous films on silicon surfaces are presented. The mechanism of the reaction of Fe(CO)4PPh3 in the films has been studied in some detail. Initial CO loss leads to a thermally unstable intermediate, Fe(CO)3PPh3, which decomposes in the film leading to the production of iron. In thick films photoproduced CO remains trapped in the film and may react with Fe(CO)3PPh3, regenerating the starting material. Further evidence for this intermediate arises from experiments conducted with PPh3 added to the film. In these films the initial photoproduct is trapped by PPh3 yielding Fe(CO)3(PPh3)2. A quantitative study of the quantum yield efficiency in these films was undertaken. The Fe(CO)3(PPh3)2 films are photosensitive undergoing CO loss to yield Fe(CO)2(PPh3)2, as demonstrated by its trapping, by PPh3, to form Fe(CO)2(PPh3)3. Extended photolysis of Fe(CO)3(PPh3)2 films, including those containing photoproduced Fe(CO)2(PPh3)3, results in the formation of iron. The surface photochemistry of both Fe(CO)4PPh3, and Fe(CO)3(PPh3)2 are shown to be compatible with standard lithography. Patterns of 1×100 μm lines of iron oxide were easily produced on a silicon surface.
website:https://www.synose.com/
Contact:86-579-82275537
Address:No.1958 Liyu Road , jinhua,zhejiang,China
Sichuan Highlight Fine Chemicals Co., Ltd.
Contact:+86-28-8525 1605
Address:A5-102 Airport base,388 West Airport Huang He Zhong Lu,2 Section
Contact:17316303296
Address:240 Amboy Ave
Xiamen Hisunny Chemical Co.,Ltd
website:http://www.hisunnychem.com
Contact:+86-592-3327115
Address:Unit 603,No.879,Xiahe Road,Meixin Building,Xiamen,China
SICHUAN TONGSHENG AMINOACID CO.LTD
website:http://www.aminoacid.cc
Contact:86-838-2274206/2850606
Address:Room 1-11-1,No.19 of North TianShan Road,Deyang,Sichuan China
Doi:10.1016/j.molliq.2019.111370
(2019)Doi:10.1107/S0108270105016185
(2005)Doi:10.1002/ejoc.201501305
(2016)Doi:10.1021/acs.molpharmaceut.0c00610
(2020)Doi:10.1021/jm5013598
(2015)Doi:10.1080/00397919308013792
(1993)